N1-苄基-4-甲基苯-1,2-二胺 | 39235-93-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: N1-苄基-4-甲基苯-1,2-二胺
• 英文名称: N¹-benzyl-4-methylbenzene-1,2-diamine
• 英文别名: N-Benzyl-4-methyl-o-phenylenediamine；1-N-benzyl-4-methylbenzene-1,2-diamine
• CAS: 39235-93-3
• 化学式: C₁₄H₁₆N₂
• 分子量: 212.294
• InChiKey: BXKFJRIHXLNJPC-UHFFFAOYSA-N

物化性质

• 熔点：
  111.9-112.4 °C
• 沸点：
  365.8±30.0 °C(Predicted)
• 密度：
  1.128±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  38
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N1-苄基-4-甲基苯-1,2-二胺 在 盐酸 、 溶剂黄146 作用下， 以 甲醇 、 水 为溶剂， 生成 3-(2-amino-5-fluorophenyl)-1-benzyl-6-methylquinoxalin-2(1H)-one
  参考文献：
  名称：

  Phenylquinoxalinone CFTR activator as potential prosecretory therapy for constipation

  摘要：

  Constipation is a common condition for which current treatments can have limited efficacy. By high-throughput screening, we recently identified a phenylquinoxalinone activator of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel that stimulated intestinal fluid secretion and normalized stool output in a mouse model of opioid-induced constipation. Here, we report phenylquinoxalinone structure-activity analysis, mechanism of action, animal efficacy data in acute and chronic models of constipation, and functional data in ex vivo primary cultured human enterocytes. Structure-activity analysis was done on 175 phenylquinoxalinone analogs, including 15 synthesized compounds. The most potent compound, CFTRact-J027, activated CFTR with EC50 similar to 200 nM, with patch-clamp analysis showing a linear CFTR current-voltage relationship with direct CFTR activation. CFTRact-J027 corrected reduced stool output and hydration in a mouse model of acute constipation produced by scopolamine and in a chronically constipated mouse strain (C3H/HeJ). Direct comparison with the approved prosecretory. drugs lubiprostone and linaclotide showed substantially greater intestinal fluid secretion with CFTRact-J027, as well as greater efficacy in a constipation model. As evidence to support efficacy in human constipation, CFTRact-J027 increased transepithelial fluid transport in enteroids generated from normal human small intestine. Also, CFTRact-J027 was rapidly metabolized in vitro in human hepatic microsomes, suggesting minimal systemic exposure upon oral administration. These data establish structure-activity and mechanistic data for phenylquinoxalinone CFTR activators, and support their potential efficacy in human constipation.

  DOI：

  10.1016/j.trsl.2016.10.003
• 作为产物：
  描述：

  4-溴-3-硝基甲苯 在 tris-(dibenzylideneacetone)dipalladium(0) 、 tin(II) chloride dihdyrate 、 caesium carbonate 、 R-(+)-1,1'-联萘-2,2'-双二苯膦 作用下， 以 乙酸乙酯 、 甲苯 为溶剂， 反应 26.0h， 生成 N1-苄基-4-甲基苯-1,2-二胺
  参考文献：
  名称：

  发现和优化作为新型选择性磷酸二酯酶10抑制剂的色酮衍生物。

  摘要：

  磷酸二酯酶10（PDE10）抑制剂作为中枢神经系统（CNS）疾病（如精神分裂症和亨廷顿氏病）的有前途的治疗剂受到了广泛关注。最近，具有新型色酮支架的命中化合物1对PDE10A表现出中等抑制作用（IC50 = 500 nM）。领先的优化方法使化合物3e的抑制活性提高（IC50为6.5 nM），选择性显着（比其他PDE高95倍），并具有良好的代谢稳定性（RLM t1 / 2 = 105分钟）集成策略（分子建模，化学合成，生物测定和共晶结构）。共晶结构信息提供了有关PDE10A催化域中3e结合模式的见解，以突出卤素和氢键对Tyr524和Tyr693的关键作用，分别导致对其他PDE的高选择性。这些新的观察结果对于合理设计用于中枢神经系统疾病的下一代PDE10抑制剂是有益的。

  DOI：

  10.1021/acschemneuro.0c00024

文献信息

• Selective reduction of aromatic nitro compounds containing o- and n-benzyl groups with hydrazine and raney nickel
  作者：Francisco Yuste、Manuel Saldaña、Fernando Walls

  DOI：10.1016/s0040-4039(00)86770-2

  日期：1982.1

  The selectiity in the catalytic reduction of aromatic nitro compounds containing O-benzyl, N-benzyl or chlorine with hydrazine and Raney nickel was studied.

  研究了用肼和阮内镍催化还原含O-苄基，N-苄基或氯的芳族硝基化合物的选择性。
• “All-water” one-pot diverse synthesis of 1,2-disubstituted benzimidazoles: hydrogen bond driven ‘synergistic electrophile–nucleophile dual activation’ by water
  作者：Damodara N. Kommi、Pradeep S. Jadhavar、Dinesh Kumar、Asit K. Chakraborti

  DOI：10.1039/c3gc37004f

  日期：——

  promoting the subsequent nitro reduction and in the final cyclocondensation steps. The role of water in promoting the cyclocondensation reaction through hydrogen bonds is realized by the differential product yields during the reaction of mono-N-phenyl-o-phenylenediamine with benzaldehyde performed separately in water and D2O. The better hydrogen bond donor and hydrogen bond acceptor abilities of water

  新的“全水”串联芳基氨基芳基化/芳基氨基烷基化–还原–环化 报道了一锅多样性导向的区域定义的1,2-二取代的合成路线 苯并咪唑。 水 通过氢键驱动的'协同亲电试剂-亲核试剂双重作用，起着至关重要的和必不可少的作用 激活在形成N-单-芳基/芳基烷基/烷基/环烷基 在无金属和无碱条件下邻硝基苯胺取代基于过渡金属的C–N键的形成（芳基 胺化）的化学成分，并强调了区域定义安装的起源，包括多种选择 芳基，芳基烷基和 烷基/环烷基作为苯并咪唑支架上的取代基以形成1,2-二取代 苯并咪唑。氢键效应的影响水通过观察D 2 O的收率低于在D 2 O中获得的收率，已经实现了在无碱和无金属条件下促进芳基氨基芳基化反应的研究。水 在反应过程中 邻氟硝基苯 和 苯胺 单独执行 水和D 2 O在相似的实验条件下。水 还提供了促进后续硝化的帮助 减少并在最后的循环冷凝步骤中。的作用水 通过氢键促进环缩合反应的过程是通过反应过程中产物收率的差异来实现的
• MRGX Receptor Antagonists
  申请人：Rheinische-Friedrich-Wilhelms-Universität Bonn

  公开号：US20210128561A1

  公开（公告）日：2021-05-06

  The invention relates to a method for preventing or treating a disease or disorder that is associated with the MrgX2 receptor. The invention also relates to MrgX2 antagonists and physiologically acceptable salts thereof. The invention also relates to pharmaceutical compositions and dosage forms comprising an MrgX2 antagonist.

  该发明涉及一种用于预防或治疗与MrgX2受体相关的疾病或紊乱的方法。该发明还涉及MrgX2拮抗剂及其生理上可接受的盐。该发明还涉及包含MrgX2拮抗剂的药物组合物和剂型。
• Construction of Druglike 2-Amido Benzo[<i>d</i>]imidazole Analogues via Desulfurative Cyclization of Thiourea Intermediate Resin on Solid-Phase
  作者：Hyun-Jeong Ryu、Seung-Ju Yang、Gee-Hyung Lee、Young-Dae Gong

  DOI：10.1021/acscombsci.8b00004

  日期：2018.5.14

  A 2-amido benzo[d]imidazole library has been constructed by solid-phase synthesis. The key step of this solid-phase synthesis involves the preparation of polymer-bound 2-amino benzo[d]imidazole resin through desulfurative cyclization of thiourea resin using 2-chloro-1,3-dimethylimidazolinium chloride and N,N-diisopropylethylamine in dichloromethane (DCM), and the resin is then functionalized by acylation

  通过固相合成已经构建了2-氨基苯并[ d ]咪唑文库。该固相合成的关键步骤涉及使用2-氯-1,3-二甲基咪唑啉鎓氯化物和N，N-二异丙基乙胺的二氯甲烷溶液，通过硫脲树脂的脱硫环化反应，制备与聚合物结合的2-氨基苯并[ d ]咪唑树脂。 （DCM），然后通过在2-胺位置上进行酰化将树脂官能化，得到2-酰胺基苯并[ d ]咪唑树脂。在具有p -I或m -NO 2的2-酰胺基苯并[ d ]咪唑树脂的情况下，通过Suzuki / Sonogashira-偶联将树脂进一步官能化（p -I）还原为伯胺（m -NO 2），然后进行酰化。最后，通过用三氟乙酸和DCM的混合物处理，将官能化的2-酰胺基-苯并[ d ]咪唑树脂从聚合物载体上裂解下来。结果，我们以高收率和良好的纯度获得了2-酰胺基苯并[ d ]咪唑类似物。
• Regioselective Nitration of <i>N</i>-Alkyl Anilines using <i>tert</i>-Butyl Nitrite under Mild Condition
  作者：Priyanka Chaudhary、Surabhi Gupta、Nalluchamy Muniyappan、Shahulhameed Sabiah、Jeyakumar Kandasamy

  DOI：10.1021/acs.joc.8b02377

  日期：2019.1.4

  Regioselective ring nitration of N-alkyl anilines is reported using tert-butyl nitrite. The reactions proceed efficiently with a wide range of substrates providing synthetically useful N-nitroso N-alkyl nitroanilines in excellent yields which can be easily converted into N-alkyl phenylenediamines and N-alkyl nitroanilines using Zn-AcOH and HCl/MeOH, respectively.

  据报道使用亚硝酸叔丁酯对N-烷基苯胺的区域选择性环硝化。该反应在多种底物下有效地进行，以优异的产率提供了合成上有用的N-亚硝基N-烷基硝基苯胺，可以分别使用Zn-AcOH和HCl / MeOH轻松地将其转化为N-烷基苯二胺和N-烷基硝基苯胺。